|Articles|October 7, 2019

The Detective Work Needed to Understand the Causes of Agitation Seen in Dementia

Key Takeaways

  • Neurodegeneration-related impairments in affective regulation and executive function, coupled with neurotransmitter pathway degradation, create a baseline vulnerability to agitation in major neurocognitive disorders.
  • Superimposed medical illness, psychiatric comorbidity, psychological stressors, iatrogenic medication effects, and environmental factors frequently precipitate or amplify behavioral disturbances.
SHOW MORE

Brain damage associated with dementia impairs affective regulation and executive function, and degrades cholinergic, serotonergic, and dopaminergic pathways. Dr Marc Agronin explains.

Dr Marc Agronin explains how determining the causes of agitation seen in dementia requires good detective work. The stage is set given the brain damage associated with dementia which impairs affective regulation and executive function, and degrades cholinergic, serotonergic, and dopaminergic pathways.

These changes are enough to cause agitation-but frequently additional medical, psychiatric, psychological, medication-related, or environmental factors actually trigger or exacerbate behavioral disturbances.

A deeper understanding of agitated behaviors can be derived from looking at their context and the function they serve. Applied behavior analysis suggests that disruptive behaviors serve one or more of these five basic functions:

• pain attenuation

• attention-seeking

• stimulation

• tangible items (eg, food)

• escape from noxious situations

It can take time and multiple interviews to understand the functions but knowing them can guide behavioral treatments.

Dr Agronin is a geriatric psychiatrist and currently serves as the Senior Vice President for Behavioral Health and the Chief Medical office at MIND Institute at Miami Jewish Health in Miami, FL. Dr Agronin was a speaker at the 2019 Psych Congress® in San Diego, CA, in a presentation titled “Behavioral and pharmacologic approaches to agitation and dementia associated with major neurocognitive disorders.”

The articles and interviews featured on this page were developed by Psychiatric Times editorial staff and contributors based on presentations delivered at Psych Congress®, an annual conference produced by HMP Global. Psychiatric Times is an independent publication and is not affiliated with, endorsed by, or sponsored by any third-party. All content on this page reflects the independent editorial judgment of Psychiatric Times and does not represent the views, positions, or communications of any third-parties.